Veterinary Diagnostics Market Analysis

  • Report ID: 6378
  • Published Date: Sep 18, 2025
  • Report Format: PDF, PPT

Veterinary Diagnostics Market Segmentation:

Product Segment Analysis

The consumable segment in the veterinary diagnostics market will account for a significant share by 2035, owing to increasing demand for diagnostics tests, consistent utilization of reagents and kits in veterinary clinics and laboratories, and continuous need for advanced technology to detect emerging diseases. Reagents, kits, and assays are some the commonly used consumables in veterinary diagnostics for varied infectious, genetic, allergy, and toxicology testing.

Technology Segment Analysis

The molecular diagnostics segment is expected to account for a 33.2% share of the veterinary diagnostics market during the forecast period due to its high sensitivity, rapid results, and accurate outcomes. This segment has revolutionized the approach to diagnosing infectious diseases, genetic disorders, and serious health issues in animals by offering efficient methods replacing traditional methods such as PCR, sequencing, and microarrays. These modern and advanced technical methods have become a benchmark in improvising timely and effective diagnosis of animal diseases.

Its ability to detect numerous targets simultaneously and provide timely results has made it an indispensable tool for researchers, veterinarians, and other animal health professionals. Moreover, the portability and easy-to-use features of such molecular diagnostics devices have expanded their reach to point-of-care settings, enabling on-site testing, and making decisions on time the driving forces behind the significant segment growth.

Animal type Segment Analysis

The companion animal segment is expected to register the fastest growth till 2035, owing to increasing pet ownership, and rising concerns about animal health. The increasing adoption of dogs, cats, and horses has resulted in growing demand for premium quality animal well-being products, including diagnostics and devices. Additionally, the growing trend of pet owners seeking human-level healthcare for their pets has led an increase in demand for specialized and sophisticated diagnostics tests and healthcare products. As a result, companies are striving to develop innovative and cost-effective diagnostics solutions for optimal outcomes of companion animal diseases.

Our in-depth analysis of the global market includes the following segments:

Product

  • Consumables
  • Instruments

Technology

 

  • Hematology
  • Immunodiagnostics
  • Molecular Diagnostics
  • Clinical biochemistry
  •  Others

Animal Type

  • Companion
  • Livestock

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of veterinary diagnostics is estimated at USD 9.93 billion.

The global veterinary diagnostics market size crossed USD 9.15 billion in 2025 and is likely to register a CAGR of more than 9.5%, exceeding USD 22.68 billion revenue by 2035.

The North America veterinary diagnostics market will dominate around 62% share by 2035, driven by increasing pet ownership across the region, growing concerns about animal health and welfare, and the presence of advanced veterinary healthcare infrastructure.

Key players in the market include Zoetis Services LLC, Virbac Corporation, Zomedica Corp, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Thermo Fisher Scientific Inc, IDEXX Laboratories Inc., Heska Corporation are some prominent companies.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos